# Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.

> **NCT00050076** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 204 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** MCC-135
- **DRUG:** MCC-135
- **DRUG:** MCC-135
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00050076
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00050076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00050076, "Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00050076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*